院内感染診断の世界市場 2020年

• 英文タイトル：Global Hospital-acquired Infection Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115602 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、院内感染診断の世界市場を調査対象にし、院内感染診断の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（機器及び試薬、消耗品）、用途別分析（病院、診療所、外来手術センター（ASC）、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott Laboratories、Roche AG、Astrazeneca PLC、Advan DX、Cepheid Inc.、Abbott、Hologic, Inc.、Becton Dickinson And Company、Bayer Schering Pharma LLC、Daiichi Sankyo ・企業別売上、市場シェア ・院内感染診断の地域別市場分析 ・院内感染診断の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・院内感染診断のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・院内感染診断のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・院内感染診断の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・院内感染診断の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・院内感染診断の種類別市場規模2015-2020：機器及び試薬、消耗品 ・院内感染診断の用途別市場規模2015-2020：病院、診療所、外来手術センター（ASC）、その他 ・院内感染診断の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Hospital-acquired Infection Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Hospital-acquired Infection Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hospital-acquired Infection Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hospital-acquired Infection Diagnostics market has been segmented into:
Instrument and Reagents
Consumables

By Application, Hospital-acquired Infection Diagnostics has been segmented into:
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hospital-acquired Infection Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Hospital-acquired Infection Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hospital-acquired Infection Diagnostics market.

The report offers in-depth assessment of the growth and other aspects of the Hospital-acquired Infection Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Hospital-acquired Infection Diagnostics Market Share Analysis
Hospital-acquired Infection Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hospital-acquired Infection Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hospital-acquired Infection Diagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Hospital-acquired Infection Diagnostics are:
Abbott Laboratories
Roche AG
Astrazeneca PLC
Advan DX
Cepheid Inc.
Abbott
Hologic, Inc.
Becton Dickinson And Company
Bayer Schering Pharma LLC
Daiichi Sankyo

レポート目次

---

Table of Contents

1 Hospital-acquired Infection Diagnostics Market Overview
1.1 Product Overview and Scope of Hospital-acquired Infection Diagnostics
1.2 Classification of Hospital-acquired Infection Diagnostics by Type
1.2.1 Global Hospital-acquired Infection Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Type in 2019
1.2.3 Instrument and Reagents
1.2.4 Consumables
1.3 Global Hospital-acquired Infection Diagnostics Market by Application
1.3.1 Overview: Global Hospital-acquired Infection Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers (ASC)
1.3.5 Others
1.4 Global Hospital-acquired Infection Diagnostics Market by Regions
1.4.1 Global Hospital-acquired Infection Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hospital-acquired Infection Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hospital-acquired Infection Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hospital-acquired Infection Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital-acquired Infection Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hospital-acquired Infection Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital-acquired Infection Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche AG
2.2.1 Roche AG Details
2.2.2 Roche AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche AG SWOT Analysis
2.2.4 Roche AG Product and Services
2.2.5 Roche AG Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astrazeneca PLC
2.3.1 Astrazeneca PLC Details
2.3.2 Astrazeneca PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astrazeneca PLC SWOT Analysis
2.3.4 Astrazeneca PLC Product and Services
2.3.5 Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advan DX
2.4.1 Advan DX Details
2.4.2 Advan DX Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advan DX SWOT Analysis
2.4.4 Advan DX Product and Services
2.4.5 Advan DX Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cepheid Inc.
2.5.1 Cepheid Inc. Details
2.5.2 Cepheid Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cepheid Inc. SWOT Analysis
2.5.4 Cepheid Inc. Product and Services
2.5.5 Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hologic, Inc.
2.7.1 Hologic, Inc. Details
2.7.2 Hologic, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hologic, Inc. SWOT Analysis
2.7.4 Hologic, Inc. Product and Services
2.7.5 Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Becton Dickinson And Company
2.8.1 Becton Dickinson And Company Details
2.8.2 Becton Dickinson And Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Becton Dickinson And Company SWOT Analysis
2.8.4 Becton Dickinson And Company Product and Services
2.8.5 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer Schering Pharma LLC
2.9.1 Bayer Schering Pharma LLC Details
2.9.2 Bayer Schering Pharma LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer Schering Pharma LLC SWOT Analysis
2.9.4 Bayer Schering Pharma LLC Product and Services
2.9.5 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Daiichi Sankyo SWOT Analysis
2.10.4 Daiichi Sankyo Product and Services
2.10.5 Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hospital-acquired Infection Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital-acquired Infection Diagnostics Players Market Share
3.2.2 Top 10 Hospital-acquired Infection Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hospital-acquired Infection Diagnostics Revenue and Market Share by Regions
4.2 North America Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Hospital-acquired Infection Diagnostics Revenue by Countries
5.1 North America Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
5.2 USA Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Hospital-acquired Infection Diagnostics Revenue by Countries
6.1 Europe Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hospital-acquired Infection Diagnostics Revenue by Countries
7.1 Asia-Pacific Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
7.2 China Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Hospital-acquired Infection Diagnostics Revenue by Countries
8.1 South America Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hospital-acquired Infection Diagnostics by Countries
9.1 Middle East & Africa Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hospital-acquired Infection Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2019-2024)
10.3 Instrument and Reagents Revenue Growth Rate (2015-2025)
10.4 Consumables Revenue Growth Rate (2015-2025)
11 Global Hospital-acquired Infection Diagnostics Market Segment by Application
11.1 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Hospital-acquired Infection Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgery Centers (ASC) Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Hospital-acquired Infection Diagnostics Market Size Forecast (2021-2025)
12.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast (2021-2025)
12.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Hospital-acquired Infection Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hospital-acquired Infection Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hospital-acquired Infection Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hospital-acquired Infection Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Hospital-acquired Infection Diagnostics Major Business
Table 7. Abbott Laboratories Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Hospital-acquired Infection Diagnostics Product and Solutions
Table 10. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche AG Corporate Information, Location and Competitors
Table 12. Roche AG Hospital-acquired Infection Diagnostics Major Business
Table 13. Roche AG Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Roche AG SWOT Analysis
Table 15. Roche AG Hospital-acquired Infection Diagnostics Product and Solutions
Table 16. Roche AG Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astrazeneca PLC Corporate Information, Location and Competitors
Table 18. Astrazeneca PLC Hospital-acquired Infection Diagnostics Major Business
Table 19. Astrazeneca PLC Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Astrazeneca PLC SWOT Analysis
Table 21. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product and Solutions
Table 22. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Advan DX Corporate Information, Location and Competitors
Table 24. Advan DX Hospital-acquired Infection Diagnostics Major Business
Table 25. Advan DX Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Advan DX SWOT Analysis
Table 27. Advan DX Hospital-acquired Infection Diagnostics Product and Solutions
Table 28. Advan DX Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cepheid Inc. Corporate Information, Location and Competitors
Table 30. Cepheid Inc. Hospital-acquired Infection Diagnostics Major Business
Table 31. Cepheid Inc. Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Cepheid Inc. SWOT Analysis
Table 33. Cepheid Inc. Hospital-acquired Infection Diagnostics Product and Solutions
Table 34. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Corporate Information, Location and Competitors
Table 36. Abbott Hospital-acquired Infection Diagnostics Major Business
Table 37. Abbott Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Hospital-acquired Infection Diagnostics Product and Solutions
Table 40. Abbott Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Hologic, Inc. Corporate Information, Location and Competitors
Table 42. Hologic, Inc. Hospital-acquired Infection Diagnostics Major Business
Table 43. Hologic, Inc. Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Hologic, Inc. SWOT Analysis
Table 45. Hologic, Inc. Hospital-acquired Infection Diagnostics Product and Solutions
Table 46. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Becton Dickinson And Company Corporate Information, Location and Competitors
Table 48. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Major Business
Table 49. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Becton Dickinson And Company SWOT Analysis
Table 51. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product and Solutions
Table 52. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bayer Schering Pharma LLC Corporate Information, Location and Competitors
Table 54. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Major Business
Table 55. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Bayer Schering Pharma LLC SWOT Analysis
Table 57. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product and Solutions
Table 58. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Daiichi Sankyo Corporate Information, Location and Competitors
Table 60. Daiichi Sankyo Hospital-acquired Infection Diagnostics Major Business
Table 61. Daiichi Sankyo Hospital-acquired Infection Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Daiichi Sankyo SWOT Analysis
Table 63. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product and Solutions
Table 64. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Hospital-acquired Infection Diagnostics Revenue Share by Players (2015-2020)
Table 67. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Regions (2015-2020)
Table 69. North America Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
Table 70. North America Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Hospital-acquired Infection Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Hospital-acquired Infection Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Hospital-acquired Infection Diagnostics Revenue by Countries (2015-2020)
Table 74. South America Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Table 77. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Hospital-acquired Infection Diagnostics Revenue Share by Type (2015-2020)
Table 79. Global Hospital-acquired Infection Diagnostics Revenue Forecast by Type (2021-2025)
Table 80. Global Hospital-acquired Infection Diagnostics Revenue by Application (2015-2020)
Table 81. Global Hospital-acquired Infection Diagnostics Revenue Share by Application (2015-2020)
Table 82. Global Hospital-acquired Infection Diagnostics Revenue Forecast by Application (2021-2025)
Table 83. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hospital-acquired Infection Diagnostics Picture
Figure 2. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Type in 2019
Figure 3. Instrument and Reagents Picture
Figure 4. Consumables Picture
Figure 5. Hospital-acquired Infection Diagnostics Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgery Centers (ASC) Picture
Figure 9. Others Picture
Figure 10. Global Hospital-acquired Infection Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Hospital-acquired Infection Diagnostics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Hospital-acquired Infection Diagnostics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Hospital-acquired Infection Diagnostics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Regions in 2018
Figure 24. North America Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. South America Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. North America Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Hospital-acquired Infection Diagnostics Revenue Market Share by Countries in 2019
Figure 31. USA Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Hospital-acquired Infection Diagnostics Revenue Market Share by Countries in 2019
Figure 36. Germany Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. UK Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. France Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Hospital-acquired Infection Diagnostics Revenue Market Share by Countries in 2019
Figure 43. China Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. India Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. South America Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Hospital-acquired Infection Diagnostics Revenue Market Share by Countries in 2019
Figure 50. Brazil Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Hospital-acquired Infection Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Global Hospital-acquired Infection Diagnostics Revenue Share by Type (2015-2020)
Figure 59. Global Hospital-acquired Infection Diagnostics Revenue Share by Type in 2019
Figure 60. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Type (2021-2025)
Figure 61. Global Instrument and Reagents Revenue Growth Rate (2015-2020)
Figure 62. Global Consumables Revenue Growth Rate (2015-2020)
Figure 63. Global Hospital-acquired Infection Diagnostics Revenue Share by Application (2015-2020)
Figure 64. Global Hospital-acquired Infection Diagnostics Revenue Share by Application in 2019
Figure 65. Global Hospital-acquired Infection Diagnostics Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Revenue Growth Rate (2015-2020)
Figure 67. Global Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgery Centers (ASC) Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Hospital-acquired Infection Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Hospital-acquired Infection Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
Figure 74. Europe Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. South America Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Hospital-acquired Infection Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---